...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases
【24h】

Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases

机译:在异常情况下基于HbA2水平的检测而无法进行β地中海贫血的携带者检测

获取原文
获取原文并翻译 | 示例

摘要

Background: An increased HbA2 level is the hallmark for identification of β thalassemia carriers. However, in some carriers the level of HbA2 is not typically elevated creating difficulties in making a diagnosis. Methods: We describe a family having an affected child referred to us for confirmation of diagnosis of β thalassemia. Results: The father has a classical β thalassemia trait and the mother showed typical reduced red cell indices with a high RBC count but the HbA2 level was normal (2.4%). On molecular analysis she was a heterozygous carrier having IVS1 nt 5 (G → C) β thalassemia mutation. Further analysis of δ globin gene showed that the reduction in HbA2 was due to the presence of the δ mutation HbA2 Pelendri [CD 141(Leu → Pro, C. TG → C. CG)]. Conclusions: The diagnosis of a β thalassemia carrier could have been compromised, and states the importance of comprehensive molecular analysis for accurate diagnosis in couples where one partner has β thalassemia trait.
机译:背景:HbA2水平升高是鉴定β地中海贫血携带者的标志。但是,在某些携带者中,HbA2的水平通常不会升高,这给诊断带来了困难。方法:我们描述了一个有患病儿童的家庭,该儿童被转介给我们以确认诊断为β地中海贫血。结果:父亲具有典型的β地中海贫血特征,母亲表现出典型的红细胞指数降低,RBC计数高,但HbA2水平正常(2.4%)。在分子分析中,她是具有IVS1 nt 5(G→C)β地中海贫血突变的杂合子载体。对δ珠蛋白基因的进一步分析表明,HbA2的减少是由于存在δ突变HbA2 Pelendri [CD 141(Leu→Pro,C. TG→C. CG)]。结论:β地中海贫血携带者的诊断可能受到损害,并指出全面分子分析对于准确诊断一对伴侣具有β地中海贫血特征的夫妇的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号